Apollo Endosurgery Valuation

Apollo Endosurgery Investor Information

About 63.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.06. Apollo Endosurgery last dividend was issued on the 30th of December 2016. The entity had 1:5 split on the 30th of December 2016. Based on the key measurements obtained from Apollo Endosurgery's financial statements, Apollo Endosurgery is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Apollo Endosurgery Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Apollo Endosurgery has an asset utilization ratio of 69.72 percent. This suggests that the Company is making $0.7 for each dollar of assets. An increasing asset utilization means that Apollo Endosurgery is more efficient with each dollar of assets it utilizes for everyday operations.

Apollo Endosurgery Ownership Allocation

Apollo Endosurgery holds a total of 47.55 Million outstanding shares. Over half of Apollo Endosurgery's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Apollo Endosurgery Profitability Analysis

The company reported the previous year's revenue of 76.86 M. Net Loss for the year was (39.84 M) with profit before overhead, payroll, taxes, and interest of 42.43 M.

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

If you are still planning to invest in Apollo Endosurgery check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apollo Endosurgery's history and understand the potential risks before investing.